Drugs / WXSH0102
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06771063 | Jan → Jul 2025 overdue | vaginitis | Cisen Pharmaceutical CO., LTD. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WXSH0102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06771063 ↗ |
| Route | Oral | “Administer WXSH0102 tablets/placebo orally.” NCT06771063 ↗ |